GGrantIndex
← Leaderboards

Luke Packard Brewster

Veterans Health Administration

$4,406,085
Attributed
$4,406,085
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $779K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,406,085 · 3
VA$0 · 3

By mechanism

R01$3,610,854 · 1
K08$689,556 · 1
F32$105,675 · 1
I01$0 · 2
I21$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Veterans Health Administration

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectIn VivoPeripheral Arterial DiseaseBlood VesselsArteriesAmputationMolecularIn VitroIn Vivo ModelPathway InteractionsSignal TransductionEndothelial CellsLeadBiologyIn Vitro TestingIn Vivo EvaluationVeteransMedicalRecruitMortalityTissuesResponsePrematureAge Related

Grant awards (24)

Pilot Investigation of Ewing Amputation in Veterans with Peripheral Arterial Disease Undergoing Below Knee Amputation$0
I01 · FY2025 · VA · contact PI
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease$0
I01 · FY2025 · VA · contact PI
Pilot Investigation of Ewing Amputation in Veterans with Peripheral Arterial Disease Undergoing Below Knee Amputation$0
I01 · FY2025 · VA · contact PI
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease$0
I01 · FY2024 · VA · contact PI
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease$0
I01 · FY2023 · VA · contact PI
Pilot Investigation of Ewing Amputation in Veterans with Peripheral Arterial Disease Undergoing Below Knee Amputation$0
I01 · FY2023 · VA · contact PI
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease$726,518
R01 · FY2022 · HL · contact PI
Pilot Investigation of Ewing Amputation in Veterans with Peripheral Arterial Disease Undergoing Below Knee Amputation$0
I01 · FY2022 · VA · contact PI
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease$0
I01 · FY2022 · VA · contact PI
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease$736,859
R01 · FY2021 · HL · contact PI
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease$0
I01 · FY2021 · VA · contact PI
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease$752,245
R01 · FY2020 · HL · contact PI
Quantifying Recovery of Muscle Strength after Exercise in Large Animal Model of Ischemic Myopathy from Peripheral Arterial Disease (PAD)$0
I21 · FY2020 · VA · contact PI
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease$0
I01 · FY2020 · VA · contact PI
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease$777,013
R01 · FY2019 · HL · contact PI
Quantifying Recovery of Muscle Strength after Exercise in Large Animal Model of Ischemic Myopathy from Peripheral Arterial Disease (PAD)$0
I21 · FY2019 · VA · contact PI
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease$618,219
R01 · FY2018 · HL · contact PI
Molecular Mechanism of Disturbed Flow in Arterial Stiffening$160,812
K08 · FY2018 · HL · contact PI
Molecular Mechanism of Disturbed Flow in Arterial Stiffening$160,812
K08 · FY2017 · HL · contact PI
Molecular Mechanism of Disturbed Flow in Arterial Stiffening$160,812
K08 · FY2016 · HL · contact PI
Molecular Mechanism of Disturbed Flow in Arterial Stiffening$103,560
K08 · FY2015 · HL · contact PI
Molecular Mechanism of Disturbed Flow in Arterial Stiffening$103,560
K08 · FY2014 · HL · contact PI
Vascular Healing with VEGF-Collagen Binding Chimera$53,366
F32 · FY2005 · HL
Vascular Healing with VEGF-Collagen Binding Chimera$52,309
F32 · FY2004 · HL